Antagonists of gonadotropin releasing hormone
First Claim
Patent Images
1. A compound of the formula whereinR0 is hydrogen, C1-C6 alkyl, substituted C1-C6 alkyl, wherein the substituents are as defined below;
- aryl, substituted aryl, aralkyl or substituted aralkyl, wherein the substituents are as defined for R3, R4 and R5;
R1 and R2 are independently hydrogen, C1-C6 alkyl, substituted C1-C6 alkyl, C3-C7 cycloalkyl, substituted C3-C7 cycloalkyl, a beterocyclic ring or bicyclic heterocyclic ring with from 1 to 4 heteroatoms selected from N, O or S which can be optionally substituted by R3, R4 and R5, C1-C6-alkyl substituted by a heterocyclic ring or bicyclic heterocyclic ring with from 1 to 4 heteroatoms selected from N, O or S which can be optionally substituted by R3, R4 and R5, C3-C6 alkenyl, substituted C3-C6 alkenyl, C3-C6 alkynyl, substituted C3-C6 alkynyl, C0-C5-alkyl-S(O)n—
C0-C5 alkyl, C2-C6 alkyl(NR11R12), C2-C6 alkyl(OR11), or C1-C6alkyl (CONR11R12);
with the proviso that R11 and R12 independently or taken together are not aryl, substituted aryl, aralkyl, or substituted aralkyl;
or R1 and R2 taken together form a non-heteroaromatic ring of 3-8 atoms containing 0,1 or 2 additional heteroatoms selected from S, O or N;
R3, R4 and R5 are independently hydrogen, C1-C6 alkyl, substituted C1-C6 alkyl, C2-C6 alkenyl, substituted C2-C6 alkenyl, CN, nitro, C1-C3 perfluoroalkyl, C1-C3 perfluoroalkoxy, R11O (CH2)p-, R11C(O)O(CH2)p-, R11OC(O)(CH2)p-, —
(CH2)pS(O)nR17, —
(CH2)pC(O)NR11R12 or halogen;
wherein R17 is hydrogen, C1-C6 alkyl, C1-C3 perfluoroalkyl;
R3 and R4 taken together form a carbocyclic ring of 3-7 carbon atoms or a heterocyclic ring containing 1-3 beteroatoms selected from N, O and S;
R6 is hydrogen, C1-C6 alkyl, substituted C1-C6 alkyl, aryl, substituted aryl, C1-C3 perfluoroalkyl, CN, NO2, halogen, R11O(CH2)p-, NR12C(O)R11, NR12C(O)NR11R12 or SOnR11;
R7 is hydrogen, C1-C6 alkyl, or substituted C1-C6 alkyl, unless X is hydrogen or halogen, then R7 is absent;
R8 is hydrogen, C(O)OR9, C(O)NR20R21, N R20R21, C(O)R11, NR20C(O)R11, NR20C(O)N R20R21, NR20S(O)2R11, NR20S(O)2NR20R21, OC(O)R11, OC(O)NR20R21, OR11, SOnR11, S(O)nNR20R21, C1-C6 alkyl or substituted C1-C6 alkyl, unless X is hydrogen or halogen, then R8 is absent;
or R7 and R8 taken together form a carbocyclic ring of 3-7 atoms;
R9 and R9a are independently hydrogen, C1-C6 alkyl, substituted C1-C6 alkyl;
aryl or substituted aryl, aralkyl or substituted aralkyl when m≠
0;
or R9 and R9a taken together form a carbocyclic ring of 3-7 atoms or when m,≠
0;
R10 and R10a are independently hydrogen, C1-C6 alkyl, substituted C1-C6 alkyl, aryl, substituted aryl, aralkyl or substituted aralkyl;
or R10 and R10a taken together form a carbocyclic ring of 3-7 atoms or R9 and R10 taken together form a carbocyclic ring of 3-7 carbon atoms or a heterocyclic ring containing one or more heteroatoms when m≠
0;
or R9 and R2 taken together form a heterocyclic ring containing 3-7 carbon atoms and one or more heteroatoms when m≠
0;
or R10 and R2 taken together form a heterocyclic ring containing 3-7 carbon atoms and one or more heteroatoms;
R11 and R12 are independently hydrogen, C1-C6 alkyl, substituted C1-C6 alkyl, aryl, substituted aryl, aralkyl, substituted aralkyl, a carbocyclic ring of 3-7 atoms or a substituted carbocyclic ring containing 3-7 atoms;
R11 and R12 taken together can form an optionally substituted ring of 3-7 atoms;
R20 and R21 are independently hydrogen, C1-C6 alkyl, substituted C1-C6 alkyl, aryl, substituted aryl, aralkyl, substituted aralkyl, a carbocyclic ring of 3-7 atoms or a substituted carbocyclic ring containing 3-7 atoms;
X is hydrogen, halogen, N, O, S(O)n, C(O), (CR11R12)p;
C2-C6 alkenyl, substituted C2-C6 alkenyl, C2-C6 alkynyl, or substituted C2-C6 alkynyl;
when X is hydrogen or halogen, R7 and R8 are absent;
when X is O, S(O)n, C(O), or CR11R12 only R7 or R8 is possible;
Z is O, S, or NR11;
m is 0-3;
n is 0-2;
p is 0-4; and
the alkyl, alkenyl and alkynyl substituents are selected from C1-C6 alkyl, C3-C7 cycloalkyl, hydroxy, oxo, cyano, C1-C6 alkoxy, fluoro, C(O)OR11, and the aryl substituents are as defined for R3, R4 and R5;
or a pharmaceutically acceptable addition salt and/or hydrate thereof, or where applicable, a geometric or optical isomer or racemic mixture thereof.
0 Assignments
0 Petitions
Accused Products
Abstract
There are disclosed compounds of formula (I)
and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related and other conditions in both men and women.
-
Citations
19 Claims
-
1. A compound of the formula
wherein R0 is hydrogen, C1-C6 alkyl, substituted C1-C6 alkyl, wherein the substituents are as defined below; - aryl, substituted aryl, aralkyl or substituted aralkyl, wherein the substituents are as defined for R3, R4 and R5;
R1 and R2 are independently hydrogen, C1-C6 alkyl, substituted C1-C6 alkyl, C3-C7 cycloalkyl, substituted C3-C7 cycloalkyl, a beterocyclic ring or bicyclic heterocyclic ring with from 1 to 4 heteroatoms selected from N, O or S which can be optionally substituted by R3, R4 and R5, C1-C6-alkyl substituted by a heterocyclic ring or bicyclic heterocyclic ring with from 1 to 4 heteroatoms selected from N, O or S which can be optionally substituted by R3, R4 and R5, C3-C6 alkenyl, substituted C3-C6 alkenyl, C3-C6 alkynyl, substituted C3-C6 alkynyl, C0-C5-alkyl-S(O)n—
C0-C5 alkyl, C2-C6 alkyl(NR11R12), C2-C6 alkyl(OR11), or C1-C6alkyl (CONR11R12);
with the proviso that R11 and R12 independently or taken together are not aryl, substituted aryl, aralkyl, or substituted aralkyl;
orR1 and R2 taken together form a non-heteroaromatic ring of 3-8 atoms containing 0,1 or 2 additional heteroatoms selected from S, O or N;
R3, R4 and R5 are independently hydrogen, C1-C6 alkyl, substituted C1-C6 alkyl, C2-C6 alkenyl, substituted C2-C6 alkenyl, CN, nitro, C1-C3 perfluoroalkyl, C1-C3 perfluoroalkoxy, R11O (CH2)p-, R11C(O)O(CH2)p-, R11OC(O)(CH2)p-, —
(CH2)pS(O)nR17, —
(CH2)pC(O)NR11R12 or halogen;
wherein R17 is hydrogen, C1-C6 alkyl, C1-C3 perfluoroalkyl;
R3 and R4 taken together form a carbocyclic ring of 3-7 carbon atoms or a heterocyclic ring containing 1-3 beteroatoms selected from N, O and S;
R6 is hydrogen, C1-C6 alkyl, substituted C1-C6 alkyl, aryl, substituted aryl, C1-C3 perfluoroalkyl, CN, NO2, halogen, R11O(CH2)p-, NR12C(O)R11, NR12C(O)NR11R12 or SOnR11;
R7 is hydrogen, C1-C6 alkyl, or substituted C1-C6 alkyl, unless X is hydrogen or halogen, then R7 is absent;
R8 is hydrogen, C(O)OR9, C(O)NR20R21, N R20R21, C(O)R11, NR20C(O)R11, NR20C(O)N R20R21, NR20S(O)2R11, NR20S(O)2NR20R21, OC(O)R11, OC(O)NR20R21, OR11, SOnR11, S(O)nNR20R21, C1-C6 alkyl or substituted C1-C6 alkyl, unless X is hydrogen or halogen, then R8 is absent;
orR7 and R8 taken together form a carbocyclic ring of 3-7 atoms;
R9 and R9a are independently hydrogen, C1-C6 alkyl, substituted C1-C6 alkyl;
aryl or substituted aryl, aralkyl or substituted aralkyl when m≠
0;
orR9 and R9a taken together form a carbocyclic ring of 3-7 atoms or when m,≠
0;R10 and R10a are independently hydrogen, C1-C6 alkyl, substituted C1-C6 alkyl, aryl, substituted aryl, aralkyl or substituted aralkyl;
orR10 and R10a taken together form a carbocyclic ring of 3-7 atoms or R9 and R10 taken together form a carbocyclic ring of 3-7 carbon atoms or a heterocyclic ring containing one or more heteroatoms when m≠
0;
orR9 and R2 taken together form a heterocyclic ring containing 3-7 carbon atoms and one or more heteroatoms when m≠
0;
orR10 and R2 taken together form a heterocyclic ring containing 3-7 carbon atoms and one or more heteroatoms;
R11 and R12 are independently hydrogen, C1-C6 alkyl, substituted C1-C6 alkyl, aryl, substituted aryl, aralkyl, substituted aralkyl, a carbocyclic ring of 3-7 atoms or a substituted carbocyclic ring containing 3-7 atoms;
R11 and R12 taken together can form an optionally substituted ring of 3-7 atoms;
R20 and R21 are independently hydrogen, C1-C6 alkyl, substituted C1-C6 alkyl, aryl, substituted aryl, aralkyl, substituted aralkyl, a carbocyclic ring of 3-7 atoms or a substituted carbocyclic ring containing 3-7 atoms;
X is hydrogen, halogen, N, O, S(O)n, C(O), (CR11R12)p;
C2-C6 alkenyl, substituted C2-C6 alkenyl, C2-C6 alkynyl, or substituted C2-C6 alkynyl;
when X is hydrogen or halogen, R7 and R8 are absent;
when X is O, S(O)n, C(O), or CR11R12 only R7 or R8 is possible;
Z is O, S, or NR11;
m is 0-3;
n is 0-2;
p is 0-4; and
the alkyl, alkenyl and alkynyl substituents are selected from C1-C6 alkyl, C3-C7 cycloalkyl, hydroxy, oxo, cyano, C1-C6 alkoxy, fluoro, C(O)OR11, and the aryl substituents are as defined for R3, R4 and R5;
or a pharmaceutically acceptable addition salt and/or hydrate thereof, or where applicable, a geometric or optical isomer or racemic mixture thereof. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)
- aryl, substituted aryl, aralkyl or substituted aralkyl, wherein the substituents are as defined for R3, R4 and R5;
Specification